Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards
ANNA T. ZABOST
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidRecherchez cet auteur sur
, , SYLWIA A. BRZEZIŃSKA
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidRecherchez cet auteur sur
, MAGDALENA D. KLATT
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidRecherchez cet auteur sur
et EWA M. AUGUSTYNOWICZ-KOPEĆ
Department of Microbiology National Tuberculosis and Lung Diseases Research InstituteWarsaw, Poland
Profil OrcidRecherchez cet auteur sur
17 sept. 2021
À propos de cet article
Catégorie d'article: original-paper
Publié en ligne: 17 sept. 2021
Pages: 315 - 320
Reçu: 31 mars 2021
Accepté: 08 juil. 2021
DOI: https://doi.org/10.33073/pjm-2021-028
Mots clés
© 2021 Anna T. Zabost et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fig. 1.
Pathogenicity of isolated M_ chimaera strains depending on sex, age, and concomitant pulmonary disease_
| NTMLD | Colonization | Total | ||
|---|---|---|---|---|
| Sex | ||||
| Men | 8 (50) | 8 (50) | 16(100) | |
| Women | 8 (57) | 6(43) | 14(100) | 0,86 |
| Age | ||||
| Years (mean+/-SD) | 58,3 (16,77) | 62,1 (12,86) | 60,1 (15,19) | 0,72 |
| Diagnosis | ||||
| Previous tuberculosis | 5 (83) | 1 (17) | 6 (100) | |
| COPD | 3 (38) | 5 (62) | 8 (100) | |
| Cystic fibrosis | 2(100) | 0 | 2 (100) | |
| Interstitial lung diseases | 2 (40) | 3 (60) | 5 (100) | |
| Post-inflammatory lung fibrosis | 0 | 3 (100) | 3 (100) | |
| Bronchiectasis | 4(100) | 0 | 4(100) | |
| Neoplastic diseases | 1 (50) | 1 (50) | 2 (100) | |
| Diabetes mellitus | 1 (50) | 1 (50) | 2 (100) | |
| Others | 0 | 4 (100) | 4 (100) | |
| No concomitant disease | 2(100) | 0 | 2 (100) | |
Clinical characteristics of patients with positive M_ chimaera isolates_
| Concomitant diseases | Number (%) of patients with a given diagnosis | ||
|---|---|---|---|
| Men | Women | Total | |
| COPD | 7 (44) | 1 (7) | 8 (27) |
| Previous tuberculosis | 5 (31) | 1 (7) | 6 (20) |
| Interstitial lung disease | 5 (31) | 0 | 5 (17) |
| Cystic fibrosis | 0 | 2 (14) | 2 (7) |
| Post-inflammatory lung fibrosis | 1 (6) | 2 (14) | 3 (10) |
| Bronchiectasis | 1 (6) | 3 (21) | 4 (13) |
| Neoplastic disease | 2 (13) | 0 | 2 (7) |
| Diabetes mellitus | 1 (6) | 1 (7) | 2 (7) |
| Others | 0 | 4 (21) | 4 (13) |
| At least 2 diagnoses | 5 (31) | 2 (14) | 7 (23) |
| No concomitant disease | 1 (6) | 1 (7) | 2 (7) |